INVESTOR RELATIONS

PRESS RELEASES

4-Dec-2003 AMARIN CORPORATION REPORTS THIRD QUARTER 2003 FINANCIAL RESULTS
3-Dec-2003 AMARIN CORPORATION PLC ANNOUNCES THIRD QUARTER 2003 EARNINGS CONFERENCE CALL
28-Oct-2003 AMARIN CORPORATION SELLS AMARIN DEVELOPMENT TO WATSON PHARMACEUTICALS, INC.
20-Oct-2003 CLASSIC SYMPTOMS OF PARKINSONS DISEASE MAY NOT BE THE MOST DISABLING
14-Oct-2003 AMARINS PRESIDENT TO RECEIVE THE OUTSTANDING ACHIEVEMENT IN PARKINSONS DISEASE AWARD
1-Oct-2003 AMARIN CORPORATION CEO TO RECEIVE 2003 MARJORIE GUTHRIE LEADERSHIP AWARD AT HUNTINGTONS SOCIETY OF AMERICAS GUTHRIE AWARDS DINNER
23-Sep-2003 AMARIN CORPORATION TO PRESENT AT FRIEDLAND CAPITALS BIOTECH, MEDICAL AND HEALTHCARE CONFERENCE
10-Sep-2003 AMARIN CORPORATION ACKNOWLEDGES RECEIPT BY WATSON PHARMACEUTICALS OF FINAL FDA APPROVAL FOR GENERIC GLUCOTROL XL® 5MG TABLETS
21-Aug-2003 AMARIN CORPORATION PLC CHIEF EXECUTIVE OFFICER TALKS TO THE WALL STREET TRANSCRIPT
11-Aug-2003 AMARIN CORPORATION REPORTS SECOND QUARTER 2003
18-Jun-2003 AMARIN CORPORATION AND ACADIA PHARMACEUTICALS SIGN PHARMACEUTICAL DEVELOPMENT AGREEMENT
3-Jun-2003 AMARIN CORPORATION REPORTS FIRST QUARTER 2003
27-May-2003 AMARIN CORPORATION PLC ANNOUNCES FIRST QUARTER 2003 EARNINGS CONFERENCE CALL
14-May-2003 AMARIN CORPORATION ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH IVAX CORPORATION
5-Mar-2003 AMARIN CORPORATION DEVELOPS GENERIC FORMULATION OF DIABETES DRUG GLUCOTROL XL ® FOR WATSON PHARMACEUTICALS
3-Mar-2003 AMARIN CORPORATION PLC APPOINTS IAN GARLAND CHIEF FINANCIAL OFFICER
3-Mar-2003 AMARIN CORPORATION TO PRESENT AT SALOMON SMITH BARNEY ANNUAL SPECIALTY PHARMACEUTICALS CONFERENCE
27-Feb-2003 AMARIN CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2002 FINANCIAL RESULTS
18-Feb-2003 AMARIN CORPORATION ANNOUNCES ZELAPAR™ RECEIVES APPROVABLE LETTER FROM FDA
3-Feb-2003 AMARIN CORPORATION ANNOUNCES FURTHER PROGRESS ON LAX-101 CLINICAL DEVELOPMENT FOR HUNTINGTON'S DISEASE
Page 1 of 2